Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 16, 16:00
Sinovac Biotech Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 423.23M |
| September 30, 2020 | -19.23M |
| June 30, 2020 | -31.09M |
| March 31, 2020 | -21.25M |
| December 31, 2019 | 24.54M |
| September 30, 2019 | 9.238M |
| June 30, 2019 | 3.932M |
| March 31, 2019 | -9.26M |
| December 31, 2018 | 6.786M |
| September 30, 2018 | 11.31M |
| June 30, 2018 | -9.256M |
| March 31, 2018 | -6.506M |
| December 31, 2016 | -2.868M |
| September 30, 2016 | -3.513M |
| June 30, 2016 | -7.087M |
| March 31, 2016 | -13.09M |
| December 31, 2015 | 12.90M |
| September 30, 2015 | -3.377M |
| June 30, 2015 | -0.64M |
| March 31, 2015 | -9.976M |
| December 31, 2014 | 2.415M |
| September 30, 2014 | -6.359M |
| June 30, 2014 | -9.094M |
| March 31, 2014 | -8.002M |
| Date | Value |
|---|---|
| December 31, 2013 | 18.56M |
| September 30, 2013 | -6.583M |
| June 30, 2013 | -3.808M |
| March 31, 2013 | -7.728M |
| December 31, 2012 | 2.969M |
| September 30, 2012 | -10.58M |
| June 30, 2012 | -9.968M |
| March 31, 2012 | -14.83M |
| December 31, 2011 | 9.765M |
| September 30, 2011 | -1.311M |
| June 30, 2011 | -1.130M |
| March 31, 2011 | -8.845M |
| December 31, 2010 | 0.528M |
| September 30, 2010 | -12.81M |
| June 30, 2010 | -8.518M |
| March 31, 2010 | -18.86M |
| December 31, 2009 | 38.81M |
| September 30, 2009 | 5.738M |
| June 30, 2009 | 7.385M |
| March 31, 2009 | -7.844M |
| December 31, 2008 | 9.605M |
| September 30, 2008 | 2.260M |
| June 30, 2008 | -2.926M |
| March 31, 2008 | -2.410M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-31.09M
Minimum
Jun 2020
423.23M
Maximum
Dec 2020
55.62M
Average
3.932M
Median
Jun 2019
Free Cash Flow (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | -15.76M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |